Cidara Therapeutics Announces Formation of Scientific Advisory Board
Comprised of World-Renowned Experts in Virology, Fungal Diseases and HematologySAN DIEGO, July 27, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, today announced the formation of a scientific advisory board (SAB) and the appointment of four leading experts in viral and fungal infections and hematology. The SAB will work closely with the Cidara management team to…
wpengineJuly 27, 2020